The GNAI3 gene auriculocondylar syndrome type 1 genetic test is a specialized diagnostic procedure available at DNA Labs UAE. This test is specifically designed to identify mutations in the GNAI3 gene, which are known to cause auriculocondylar syndrome type 1 (ACS1). ACS1 is a rare genetic disorder characterized by malformations of the ears, mandible, and temporomandibular joint, leading to distinctive facial features and potentially impacting speech and eating.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to pinpoint any genetic abnormalities in the GNAI3 gene. The process involves advanced genetic sequencing technologies to ensure accurate and reliable results.
The cost of the GNAI3 gene auriculocondylar syndrome type 1 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately diagnose this rare condition.
Opting for this test at DNA Labs UAE offers patients and their families the opportunity to gain crucial insights into the genetic basis of auriculocondylar syndrome type 1. This information can be invaluable for understanding the condition, making informed medical and lifestyle decisions, and assessing the risk of passing the gene mutation to future generations.
The PLCB4 Gene Auriculocondylar Syndrome Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PLCB4 gene, which are linked to Auriculocondylar Syndrome Type 2 (ACS2). ACS2 is a rare genetic disorder characterized by anomalies in the structure of the ear (auricular) and the mandible (condylar), among other possible symptoms including facial asymmetry and issues with the heart and lungs. This condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
The test, priced at 4400 AED, involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed to detect mutations in the PLCB4 gene. Early diagnosis through genetic testing like the PLCB4 Gene Auriculocondylar Syndrome Type 2 Genetic Test is crucial for the management of the condition. It enables healthcare providers to offer appropriate treatments and interventions, and allows families to understand the risk of passing the condition to future generations. Conducted in the advanced facilities of DNA Labs UAE, this test represents a key step in the journey towards personalized medicine for patients with ACS2, offering them hope for a better quality of life through tailored care and management strategies.
The COL2A1 gene achondrogenesis type 2 genetic test is a specialized diagnostic tool used to identify mutations in the COL2A1 gene, which are linked to achondrogenesis type 2, a severe skeletal disorder that affects fetal development. This condition is characterized by a lack of bone formation, particularly in the spine and limbs, leading to extremely short limbs, underdeveloped lungs, and other life-threatening complications. The test is crucial for early diagnosis, allowing for appropriate genetic counseling and management strategies for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers comprehensive analysis with accuracy and reliability at the forefront. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to conduct this intricate examination. By identifying specific mutations in the COL2A1 gene, the test provides essential information for expecting parents, helping them understand the risks and implications of achondrogenesis type 2, and supports healthcare professionals in preparing for the medical needs of the affected newborns.
The PRKAR1A Gene Acrodysostosis Type 1 with or Without Hormone Resistance Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE. Priced at 4400 AED, this test is designed to detect mutations in the PRKAR1A gene, which are associated with Acrodysostosis Type 1. Acrodysostosis is a rare genetic disorder characterized by skeletal abnormalities, short stature, and, in some cases, resistance to certain hormones. The test aims to provide crucial information for the accurate diagnosis and management of the condition, potentially guiding treatment options for those affected. By analyzing an individual's genetic material, the test can confirm the presence of the specific mutations in the PRKAR1A gene, offering insights into whether the patient may exhibit hormone resistance alongside the skeletal manifestations of Acrodysostosis Type 1. DNA Labs UAE provides this comprehensive genetic testing service, employing advanced techniques to ensure accurate and reliable results for patients and their families.
The ZSWIM6 gene is implicated in a rare genetic disorder known as acromelic frontonasal dysostosis. This condition is characterized by distinctive facial features, limb abnormalities, and other developmental anomalies. Given the rarity and complexity of this disorder, genetic testing for mutations in the ZSWIM6 gene is crucial for accurate diagnosis and management.
DNA Labs UAE offers a specialized genetic test targeting the ZSWIM6 gene to diagnose acromelic frontonasal dysostasis. This test is a vital tool for clinicians and genetic counselors, enabling them to understand the genetic underpinnings of the disorder in affected individuals. Through a detailed analysis of the ZSWIM6 gene, the test can identify specific mutations that cause the condition, providing essential information for diagnosis, treatment planning, and genetic counseling.
The cost of the ZSWIM6 Gene Acromelic Frontonasal Dysostosis Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the technical processes of extracting DNA, analyzing the specific gene sequences, and interpreting the results to provide a comprehensive report. Given the specialized nature of this test and the expertise required to interpret its results, the cost reflects the high level of precision and care provided by DNA Labs UAE in assisting families and individuals in navigating the complexities of genetic disorders.
The NPR2 gene acromesomelic dysplasia Maroteaux type genetic test is a specialized diagnostic procedure aimed at identifying mutations in the NPR2 gene, which are responsible for causing acromesomelic dysplasia Maroteaux type (AMDM). AMDM is a rare genetic disorder characterized by severe shortening of the bones in the arms and legs, among other skeletal abnormalities. The test involves analyzing the patient's DNA to detect any genetic alterations in the NPR2 gene that could lead to the condition.
This genetic test is crucial for accurate diagnosis, allowing for appropriate management and counseling for affected individuals and their families. It can also provide valuable information for prospective parents with a family history of AMDM, helping them understand their risks of passing the condition to their offspring.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is set at 3200 AED. Given the complexity of genetic testing and the specialized analysis required, this price reflects the comprehensive service provided, including the expertise of the laboratory technicians and genetic counselors who may be involved in interpreting the results.
The FBN1 Gene Acromicric Dysplasia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FBN1 gene, which are linked to the development of Acromicric Dysplasia. This rare genetic disorder is characterized by short stature, short hands and feet, and distinctive facial features. The test is crucial for accurate diagnosis, enabling targeted interventions and management of the condition. Priced at 4400 AED, the test involves analyzing the patient's DNA to detect specific genetic alterations in the FBN1 gene, providing valuable insights for patients and their families regarding the condition's prognosis and potential genetic counseling needs.
The DLL4 Gene Adams-Oliver Syndrome Type 6 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the DLL4 gene that are associated with Adams-Oliver Syndrome Type 6. Adams-Oliver Syndrome is a rare genetic disorder characterized by the combination of scalp defects, congenital heart defects, and limb abnormalities. The Type 6 variant of this syndrome, linked to mutations in the DLL4 gene, underscores the importance of precise genetic testing for accurate diagnosis and management.
Priced at 4400 AED, this genetic test involves collecting a DNA sample, typically through a blood draw, and examining it for specific mutations in the DLL4 gene. The outcome of this test can provide crucial information for affected individuals and their families, including insights into the risk of transmitting the syndrome to offspring, and guiding personalized treatment and management plans. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test represents a critical step in the diagnostic process for individuals suspected of having Adams-Oliver Syndrome Type 6, ensuring they receive the most appropriate care and interventions based on their genetic makeup.
The TP63 Gene ADULT Syndrome Split Hand-Foot Malformation Genetic Test is a specialized diagnostic tool designed to identify mutations in the TP63 gene, which are associated with ADULT syndrome and Split Hand-Foot Malformation (SHFM). ADULT syndrome is a rare genetic disorder characterized by ectrodactyly, dysplasia of nails, and other anomalies, while SHFM involves limb malformations affecting the central digits of the hands and feet. These conditions are part of a spectrum of disorders that can result from mutations in the TP63 gene, which plays a crucial role in the development and differentiation of epithelial tissues.
The test is conducted at DNA Labs UAE, a leading genetic testing facility that offers a wide range of genetic diagnostic services. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately identify and interpret the relevant genetic mutations. This test is essential for individuals with a clinical suspicion of ADULT syndrome or SHFM, as a positive result can confirm the diagnosis, inform clinical management, and provide valuable information for family planning.
The GMPPA gene Alacrima Achalasia and Mental Retardation Syndrome (AAMR) genetic test is a specialized diagnostic procedure aimed at identifying mutations in the GMPPA gene, which are associated with the rare AAMR syndrome. This condition is characterized by a trio of primary symptoms: alacrima (a lack of tears), achalasia (a disorder affecting the ability of the esophagus to move food toward the stomach), and mental retardation. Given the complexity and rarity of this syndrome, genetic testing plays a crucial role in its diagnosis and management.
Performed at DNA Labs UAE, the test is conducted through a comprehensive analysis of the patient's DNA, specifically targeting the GMPPA gene to detect any abnormalities or mutations that could indicate the presence of AAMR syndrome. The procedure is highly technical, requiring a sample of the patient's blood or saliva, from which DNA is extracted and meticulously examined for the genetic markers of the syndrome.
The cost of the GMPPA gene AAMR syndrome genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated nature of the testing process and the specialized expertise required to interpret the results accurately. Upon completion, the test provides valuable insights that can guide healthcare professionals in developing an effective treatment and management plan for individuals diagnosed with this challenging condition.
